- - -









- - -
Investment opportunities

Tips from an insider: Five innovative tech startups

Tips from an insider: Stockholm tech start-ups

5 hot life science firms in Stockholm

Stockholm's top five infrastructure projects

Four Stockholm-based ICT firms to watch

Stockholm pioneers life science research

ICT startups offer investment opportunity

Swedish companies ready for exit

Five med-tech investment opportunities

Six cleantech investment opportunities

- - -
Rankings and surveys

Sweden tops English-language skills ranking

Sweden ranked world's best country to grow old

Swedish passport world's best for travellers

Sweden second best country for mothers

Stockholm climbs in competitiveness rankings

Sweden among best countries to be born

Fortune: 'Stockholm top place for startups'

Sweden tops first global Web Index

Sweden world's second most innovative country

Stockholm world's 6th 'best city'

'Cool Stockholm' most competitive Nordic capital

Sweden has (second) best reputation in the world

Sweden among top in Internet download speed

Sweden scores highest in 'Rule of law index'

Stockholm world's No1 in intellectual capital

Sweden the world's most ICT-competitive country

Sweden great place for moms – but Norway better

Swedes place 4th in English skills ranking

Sweden among top ICT countries

Sweden’s 10 greenest brands

‘Sweden needs to sell itself more’

Sweden overtakes the US in competitiveness

Sweden 10th ‘most admired country globally’

Sweden climbs in 'doing business' ranking

Sweden among world's least corrupt nations

Sweden's mortality rates world's second lowest

Sweden a good place to die – but Britain is best

Children in Sweden have best lives

Sweden the most competitive EU nation

Safe to do business with Swedes

How Sweden became an innovation frontrunner

Nordic countries world's most food-secure

Sweden the world’s best country – politically

Swedish firms among world's top brands

Swedish brands climb in global ranking

Sweden tops government ranking - while US lags 

'Swedish model' outranks 'American dream'  

Sweden among world's least corrupt nations

The Swedish Wire is a media production company that provides high-quality text, image and video content for international clients.


Press release published at The Swedish Wire
At Karo Bio AB's annual general meeting on Tuesday June 12th, 2012, the following was resolved.

No dividend is to be paid for the financial year 2011.

Board of Directors
Per Bengtsson, re-election
Christer Fåhraeus, re-election
Per Anders Johansson, new election
Anders Waas, re-election
Göran Wessman, re-election
Göran Wessman was elected Chairman of the Board.

PricewaterhouseCoopers AB are elected as auditors for the time until the end of the annual general meeting 2013.

Nominating Committee
The annual general meeting resolved that the five largest shareholders, not represented in the Karo Bio Board, shall appoint one representative each, which shall be members of the nominating committee until the 2013 annual general meeting. The Chairman of the Karo Bio Board shall be the convener of the nominating committee. The representatives shall be appointed and announced no later than six months before the annual general meeting 2013.

Guidelines for remuneration of the executive management
The annual general meeting resolved to adopt the board of director's proposal regarding guidelines for remuneration of the executive management of Karo Bio.

Authorization of the Board of Directors to issue new shares
Regarding item 20 on the agenda, Authorization of the Board of Directors to issue new shares, the Annual General Meeting decided in accordance with the proposal presented in advance. The Annual General Meeting authorized the Board of Directors to resolve to issue new shares with the right to subscribe to Azimuth Opportunity Ltd, on one or more occasions prior to the next annual general meeting, without regard to shareholders' pre-emption rights. It shall be possible to make issues for cash payment or set-off. The number of shares possible to issue pursuant to the authorization shall not be limited in a way other than as is prescribed by the Articles of Association applicable from time to time concerning limits on the number of shares and share capital. The reason for deviating from the shareholders' pre-emption rights shall be that the Company should be able to utilize the financing in accordance with the financing agreement that the Company has entered into with Azimuth Opportunity Ltd. The subscription price shall be determined in accordance with what is stated in the aforementioned agreement.

For further information, please contact:
CEO Per Bengtsson: cell: +46 734 474 128 or by e-mail: per.bengtsson@karobio.se

About Karo Bio
Karo Bio is a pharmaceutical company focused on the research and development of innovative drugs for large medical needs. The company runs a number of drug development projects within the indication areas neuropsychiatry, inflammation, autoimmune diseases, cancer and women's health. An important foundation for the company's activities is its unique knowledge of nuclear receptors as target proteins for the development of novel pharmaceuticals, as well as related mechanisms of action. Karo Bio is based in Huddinge, Sweden, has around 45 employees and is listed on NASDAQ OMX Stockholm (Reuters: KARO.ST).

Karo Bio publishes this information in accordance with the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was published on June 13, 2012, at 08:30 am CET

This press release is also available online at www.karobio.com and www.newsroom.cision.com.

This information was distributed by Cision

Latest Jobs for English speakers in Sweden


Jobs for English speakers in Sweden

Most Read Searched